Suraksha Diagno.

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE877V01027
  • NSEID: SURAKSHA
  • BSEID: 544293
INR
275.35
-1.75 (-0.63%)
BSENSE

Jun 08, 03:30 PM

BSE+NSE Vol: 17.22 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Net Sales
310.41
252.09
218.71
Other Operating Income
0.00
0.00
0.00
Total Operating income
310.41
252.09
218.71
Raw Material Cost
36.48
29.52
27.25
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
53.26
42.89
40.07
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
125.28
98.44
81.32
Total Expenditure (Excl Depreciation)
215.02
170.85
148.64
Operating Profit (PBDIT) excl Other Income
95.39
81.24
70.07
Other Income
3.16
3.85
3.55
Operating Profit (PBDIT)
98.55
85.09
73.62
Interest
12.55
8.39
8.79
Exceptional Items
0.00
0.00
-0.78
Gross Profit (PBDT)
86.00
76.70
64.05
Depreciation
41.45
35.30
32.60
Profit Before Tax
44.56
41.41
31.45
Tax
13.15
10.43
8.33
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
31.40
30.98
23.13
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
31.40
30.98
23.13
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.78
0.85
0.50
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32.19
31.82
23.63
Equity Capital
10.42
10.42
6.90
Face Value
2.0
2.0
2.0
Reserves
234.43
200.82
170.88
Earnings per share (EPS)
6.18
6.11
5.48
Diluted Earnings per share
6.18
5.97
5.45
Operating Profit Margin (Excl OI)
30.73%
32.23%
32.04%
Gross Profit Margin
27.71%
30.43%
29.29%
PAT Margin
10.12%
12.29%
10.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 23.13% vs 15.26% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 1.16% vs 34.66% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 17.42% vs 15.94% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 49.58% vs -4.55% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Suraksha Diagno. With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
310.41
772.77
-462.36
-59.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
310.41
772.77
-462.36
-59.83%
Raw Material Cost
36.48
179.05
-142.57
-79.63%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
53.26
140.48
-87.22
-62.09%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
61.71
-61.71
-100.00%
Other Expenses
125.28
179.66
-54.38
-30.27%
Total Expenditure (Excl Depreciation)
215.02
560.90
-345.88
-61.67%
Operating Profit (PBDIT) excl Other Income
95.39
211.87
-116.48
-54.98%
Other Income
3.16
43.39
-40.23
-92.72%
Operating Profit (PBDIT)
98.55
255.26
-156.71
-61.39%
Interest
12.55
34.36
-21.81
-63.47%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
86.00
220.90
-134.90
-61.07%
Depreciation
41.45
90.46
-49.01
-54.18%
Profit Before Tax
44.56
130.44
-85.88
-65.84%
Tax
13.15
28.94
-15.79
-54.56%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
31.40
101.50
-70.10
-69.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
31.40
101.50
-70.10
-69.06%
Share in Profit of Associates
0.00
-0.07
0.07
100.00%
Minority Interest
0.78
0.00
0.78
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32.19
101.43
-69.24
-68.26%
Equity Capital
10.42
16.22
-5.80
-35.76%
Face Value
2.00
5.00
0.00
Reserves
234.43
964.17
-729.74
-75.69%
Earnings per share (EPS)
6.18
31.27
-25.09
-80.24%
Diluted Earnings per share
6.18
30.88
-24.70
-79.99%
Operating Profit Margin (Excl OI)
30.73%
27.42%
0.00
3.31%
Gross Profit Margin
27.71%
28.59%
0.00
-0.88%
PAT Margin
10.12%
13.13%
0.00
-3.01%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 310.41 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 23.13% vs 15.26% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 32.19 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 1.16% vs 34.66% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 95.39 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 17.42% vs 15.94% in Mar 2025

Annual - Interest
Interest 12.55 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 49.58% vs -4.55% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.73%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025